HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of dermatomyositis with severe retinopathy in a patient who died of acute interstitial pneumonia].

Abstract
Sight threatening ocular complications are rare in adult patients with dermatomyositis. We encountered a 52-year-old female with dermatomyositis who had severe visual disturbance and rapidly progressive intersitial pneumonia. She was admitted to our hospital because of skin erythema, general fatigue, mild fever, and severe bilateral visual disturbance. Rentinal hemorrhages, cotton wool spots, and macular edema were observed in her fundus at the first ophthalmic examination. A diagnosis of dermatomyositis was made because of the myogenic pattern of her electromyogram, elevation of serum creatine kinase, and skin lesions. Oral prednisolone treatment was started and the retinopathy was improved, but was complicated by acute interstitial pneumonia. The interstitial pneumonia was not respond to steroid pulse therapy with methylprednisolone, and the patient died of respiratory failure on the 47th day after the onset of visual symptoms. In adult dermatomyositis patients, the complication of severe retinopathy should be considered as a risk factor for rapid progress of interstitial pneumonia.
AuthorsT Enoki, T Nakagami, A Murakami, S Okisaka, I Nakabayasi, N Yoshizawa
JournalNippon Ganka Gakkai zasshi (Nippon Ganka Gakkai Zasshi) Vol. 101 Issue 5 Pg. 441-5 (May 1997) ISSN: 0029-0203 [Print] Japan
PMID9170852 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Prednisolone
  • Methylprednisolone
Topics
  • Acute Disease
  • Anti-Inflammatory Agents (administration & dosage)
  • Dermatomyositis (complications, drug therapy)
  • Disease Progression
  • Fatal Outcome
  • Female
  • Humans
  • Lung Diseases, Interstitial (drug therapy, etiology)
  • Methylprednisolone (administration & dosage)
  • Middle Aged
  • Prednisolone (administration & dosage)
  • Retinal Diseases (drug therapy, etiology)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: